Cargando…

Does a Consumer-Targeted Deprescribing Intervention Compromise Patient-Healthcare Provider Trust? †

One in four community-dwelling older adults is prescribed an inappropriate medication. Educational interventions aimed at patients to reduce inappropriate medications may cause patients to question their prescriber’s judgment. The objective of this study was to determine whether a patient-focused de...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Yi Zhi, Turner, Justin P., Martin, Philippe, Tannenbaum, Cara
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6024917/
https://www.ncbi.nlm.nih.gov/pubmed/29659488
http://dx.doi.org/10.3390/pharmacy6020031
_version_ 1783336163546759168
author Zhang, Yi Zhi
Turner, Justin P.
Martin, Philippe
Tannenbaum, Cara
author_facet Zhang, Yi Zhi
Turner, Justin P.
Martin, Philippe
Tannenbaum, Cara
author_sort Zhang, Yi Zhi
collection PubMed
description One in four community-dwelling older adults is prescribed an inappropriate medication. Educational interventions aimed at patients to reduce inappropriate medications may cause patients to question their prescriber’s judgment. The objective of this study was to determine whether a patient-focused deprescribing intervention compromised trust between older adults and their healthcare providers. An educational brochure was distributed to community-dwelling older adults by community pharmacists in order to trigger deprescribing conversations. At baseline and 6-months post-intervention, participants completed the Primary Care Assessment Survey, which measures patient trust in doctors and pharmacists. Changes in trust were ascertained post-intervention. Proportions with 95% confidence intervals (CI), and logistic regression were used to determine a shift in trust and associated predictors. 352 participants responded to the questionnaire at both time points. The majority of participants had no change or gained trust in their doctors for items related to the choice of medical care (78.5%, 95% CI = 74.2–82.8), communication transparency (75.4%, 95% CI = 70.7–79.8), and overall trust (81.9%, 95% CI = 77.9–86.0). Similar results were obtained for participants’ perceptions of their pharmacists, with trust remaining intact for items related to the choice of medical care (79.4%, 95% CI = 75.3–83.9), transparency in communicating (82.0%, 95% CI = 78.0–86.1), and overall trust (81.6%, 95% CI = 77.5–85.7). Neither age, sex nor the medication class targeted for deprescribing was associated with a loss of trust. Overall, the results indicate that patient-focused deprescribing interventions do not shift patients’ trust in their healthcare providers in a negative direction.
format Online
Article
Text
id pubmed-6024917
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-60249172018-07-09 Does a Consumer-Targeted Deprescribing Intervention Compromise Patient-Healthcare Provider Trust? † Zhang, Yi Zhi Turner, Justin P. Martin, Philippe Tannenbaum, Cara Pharmacy (Basel) Brief Report One in four community-dwelling older adults is prescribed an inappropriate medication. Educational interventions aimed at patients to reduce inappropriate medications may cause patients to question their prescriber’s judgment. The objective of this study was to determine whether a patient-focused deprescribing intervention compromised trust between older adults and their healthcare providers. An educational brochure was distributed to community-dwelling older adults by community pharmacists in order to trigger deprescribing conversations. At baseline and 6-months post-intervention, participants completed the Primary Care Assessment Survey, which measures patient trust in doctors and pharmacists. Changes in trust were ascertained post-intervention. Proportions with 95% confidence intervals (CI), and logistic regression were used to determine a shift in trust and associated predictors. 352 participants responded to the questionnaire at both time points. The majority of participants had no change or gained trust in their doctors for items related to the choice of medical care (78.5%, 95% CI = 74.2–82.8), communication transparency (75.4%, 95% CI = 70.7–79.8), and overall trust (81.9%, 95% CI = 77.9–86.0). Similar results were obtained for participants’ perceptions of their pharmacists, with trust remaining intact for items related to the choice of medical care (79.4%, 95% CI = 75.3–83.9), transparency in communicating (82.0%, 95% CI = 78.0–86.1), and overall trust (81.6%, 95% CI = 77.5–85.7). Neither age, sex nor the medication class targeted for deprescribing was associated with a loss of trust. Overall, the results indicate that patient-focused deprescribing interventions do not shift patients’ trust in their healthcare providers in a negative direction. MDPI 2018-04-16 /pmc/articles/PMC6024917/ /pubmed/29659488 http://dx.doi.org/10.3390/pharmacy6020031 Text en © 2018 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Brief Report
Zhang, Yi Zhi
Turner, Justin P.
Martin, Philippe
Tannenbaum, Cara
Does a Consumer-Targeted Deprescribing Intervention Compromise Patient-Healthcare Provider Trust? †
title Does a Consumer-Targeted Deprescribing Intervention Compromise Patient-Healthcare Provider Trust? †
title_full Does a Consumer-Targeted Deprescribing Intervention Compromise Patient-Healthcare Provider Trust? †
title_fullStr Does a Consumer-Targeted Deprescribing Intervention Compromise Patient-Healthcare Provider Trust? †
title_full_unstemmed Does a Consumer-Targeted Deprescribing Intervention Compromise Patient-Healthcare Provider Trust? †
title_short Does a Consumer-Targeted Deprescribing Intervention Compromise Patient-Healthcare Provider Trust? †
title_sort does a consumer-targeted deprescribing intervention compromise patient-healthcare provider trust? †
topic Brief Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6024917/
https://www.ncbi.nlm.nih.gov/pubmed/29659488
http://dx.doi.org/10.3390/pharmacy6020031
work_keys_str_mv AT zhangyizhi doesaconsumertargeteddeprescribinginterventioncompromisepatienthealthcareprovidertrust
AT turnerjustinp doesaconsumertargeteddeprescribinginterventioncompromisepatienthealthcareprovidertrust
AT martinphilippe doesaconsumertargeteddeprescribinginterventioncompromisepatienthealthcareprovidertrust
AT tannenbaumcara doesaconsumertargeteddeprescribinginterventioncompromisepatienthealthcareprovidertrust